x

Developing Technology with the Potential to Dramatically Change Lives

Our Passionate Pursuit to Make a Difference Begins with Our Pipeline

Over the past 10 years, Neurelis has researched diligently to develop a pipeline of products with the potential to dramatically alter how patients challenged with epilepsy or acute anxiety episodes are treated.

Current areas of focus

An investigational product candidate being developed as an on-hand rescue therapy for intermittent use to control increased bouts of seizure activity (seizure emergencies).

NRL-1

A drug candidate being developed as on-hand rescue treatment for intermittent use to control acute anxiety episodes or panic attacks.

NRL-2

A drug candidate being developed as a non-invasive acute therapy to stop seizures that have progressed to status epilepticus.

NRL-3